LASIK for −6.00 to −12.00 D of Myopia with up to 3.00 D of Cylinder Using the ALLEGRETTO WAVE: 3- and 6-Month Results with the 200- and 400-Hz Platforms

Dr Stonecipher is a consultant to Alcon Laboratories Inc, Ft Worth, Texas, and is on their speaker’s bureau. He was an investigator in the clinical trials leading to US Food and Drug Administration (FDA) approval for the ALLEGRETTO laser. Dr Kezirian is the owner of SurgiVision Consultants Inc, Scottsdale, Arizona, maker of both SurgiVision DataLink software and Refractive Surgery Consultant Elite. He also ran the studies that led to all FDA approvals of the WaveLight laser platforms in the United States. He has current or recent consulting arrangements with Alcon Laboratories Inc, Ft Worth, Texas; Bausch & Lomb Inc, Rochester, New York; and Abbott Medical Optics, Santa Ana, California. Ms Stonecipher has no financial or proprietary interests in the materials presented herein.